术后多模式阿片类药物节约方案与标准阿片类药物处方对膝关节或肩关节镜术后阿片类药物消耗的影响:一项随机临床试验
这项在加拿大安大略省3个临床中心开展的随机临床试验纳入200例成人门诊膝或肩关节镜手术患者,比较多模式阿片节约方案与标准阿片处方的效果。结果显示,阿片节约组术后6周阿片消耗量显著低于对照组(中位数0 mg vs 40.0 mg,P < .001),处方阿片量也显著减少,但不良事件无显著差异。
要点
- 阿片节约组术后6周阿片消耗中位数0 mg,显著低于标准组40.0 mg(P < .001)。
- 标准组出院时处方阿片量均值341.2 mg,阿片节约组40.4 mg,差异显著(P < .001)。
- 标准组药物相关不良事件报告率32%,高于阿片节约组19%(P = .048)。
核心结论
- 在膝或肩关节镜手术患者中,与标准阿片处方相比,多模式阿片节约术后疼痛管理方案显著减少了术后6周内的阿片类药物消耗。
研究设计与样本
- 随机临床试验,在加拿大安大略省3个临床中心进行,2021年3月至2022年3月入组200例成人门诊膝或肩关节镜手术患者,术后随访6周,最终随访于2022年4月完成。
主要发现
- 阿片节约组术后6周口服吗啡当量消耗中位数0 mg(IQR 0-8.0 mg),显著低于标准组40.0 mg(IQR 7.5-105.0 mg)(z = -6.55;P < .001)。
- 5个预设次要终点中4个无显著差异。
- 出院时处方口服吗啡当量均值:标准组341.2 mg(95% CI 310.2-372.2),阿片节约组40.4 mg(95% CI 39.6-41.2),均值差300.8 mg(95% CI 269.4-332.3;P < .001)。
- 术后6周不良事件:标准组2例(2.1%),阿片节约组3例(3.2%),无显著差异;药物相关不良事件报告率标准组32%,阿片节约组19%(P = .048)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: In arthroscopic knee and shoulder surgery, there is growing evidence that opioid-sparing protocols may reduce postoperative opioid consumption while adequately addressing patients' pain. However, there are a lack of prospective, comparative trials evaluating their effectiveness. OBJECTIVE: To evaluate the effect of a multimodal, opioid-sparing approach to postoperative pain management compared with the current standard of care in patients undergoing arthroscopic shoulder or knee surgery. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was performed at 3 clinical sites in Ontario, Canada, and enrolled 200 patients from March 2021 to March 2022 with final follow-up completed in April 2022. Adult patients undergoing outpatient arthroscopic shoulder or knee surgery were followed up for 6 weeks postoperatively. INTERVENTIONS: The opioid-sparing group (100 participants randomized) received a prescription of naproxen, acetaminophen (paracetamol), and pantoprazole; a limited rescue prescription of hydromorphone; and a patient educational infographic. The control group (100 participants randomized) received the current standard of care determined by the treating surgeon, which consisted of an opioid analgesic. MAIN OUTCOMES AND MEASURES: The primary outcome was postoperative oral morphine equivalent (OME) consumption at 6 weeks after surgery. There were 5 secondary outcomes, including pain, patient satisfaction, opioid refills, quantity of OMEs prescribed at the time of hospital discharge, and adverse events at 6 weeks all reported at 6 weeks after surgery. RESULTS: Among the 200 patients who were randomized (mean age, 43 years; 73 women [38%]), 193 patients (97%) completed the trial; 98 of whom were randomized to receive standard care and 95 the opioid-sparing protocol. Patients in the opioid-sparing protocol consumed significantly fewer opioids (median, 0 mg; IQR, 0-8.0 mg) than patients in the control group (median, 40.0 mg; IQR, 7.5-105.0; z = -6.55; P < .001). Of the 5 prespecified secondary end points, 4 showed no significant difference. The mean amount of OMEs prescribed was 341.2 mg (95% CI, 310.2-372.2) in the standard care group and 40.4 mg (95% CI, 39.6-41.2) in the opioid-sparing group (mean difference, 300.8 mg; 95% CI, 269.4-332.3; P < .001). There was no significant difference in adverse events at 6 weeks (2 events [2.1%] in the standard care group vs 3 events [3.2%] in the opioid-sparing group), but more patients reported medication-related adverse effects in the standard care group (32% vs 19%, P = .048). CONCLUSIONS AND RELEVANCE: Among patients who underwent arthroscopic knee or shoulder surgery, a multimodal opioid-sparing postoperative pain management protocol, compared with standard opioid prescribing, significantly reduced postoperative opioid consumption over 6 weeks. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04566250.
引用
- Gazendam A, Ekhtiari S, Horner NS, et al. Effect of a Postoperative Multimodal Opioid-Sparing Protocol vs Standard Opioid Prescribing on Postoperative Opioid Consumption After Knee or Shoulder Arthroscopy: A Randomized Clinical Trial. JAMA. 2022. PMID: 36194219. doi:10.1001/jama.2022.16844
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。